The risk of cardiotoxicity associated with EGFR-TKIs is particularly linked to patients’ cardiovascular history, and elderly individuals are more susceptible to cardiovascular diseases (Sadasivan et al., 2020). The gene discussed is EGFR; the disease is cardiovascular disorder.